Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOLLITROPIN BETA for Ovulation induction: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 86 adverse event reports in the FDA FAERS database where FOLLITROPIN BETA was used for Ovulation induction.

Most Reported Side Effects for FOLLITROPIN BETA

Side Effect Reports % Deaths Hosp.
Ovarian hyperstimulation syndrome 163 70.3% 0 135
Abdominal distension 89 38.4% 0 77
Abdominal pain 82 35.3% 0 69
Nausea 46 19.8% 0 39
Chest discomfort 37 16.0% 0 32
Vomiting 32 13.8% 0 27
Tension 29 12.5% 0 29
Dyspnoea 26 11.2% 0 25
Ascites 19 8.2% 0 14
Asthenia 19 8.2% 0 17
Abdominal discomfort 16 6.9% 0 15
Dizziness 14 6.0% 0 11
Generalised tonic-clonic seizure 14 6.0% 0 0
Condition aggravated 13 5.6% 0 0
Drug ineffective 13 5.6% 0 0

Other Indications for FOLLITROPIN BETA

Assisted reproductive technology (60) In vitro fertilisation (45) Controlled ovarian stimulation (21) Superovulation (13) Hypothalamo-pituitary disorder (10) Infertility female (10) Hormone therapy (9) Infertility (5)

Other Drugs Used for Ovulation induction

CHORIOGONADOTROPIN ALFA (460) FOLLITROPIN (249) CLOMIPHENE (124) LETROZOLE (122) MENOTROPINS (107) LUTROPIN ALFA (86) TRIPTORELIN (73) LEUPROLIDE (64) GONADOTROPHIN, CHORIONIC (57) CETRORELIX (56)

Related Pages

FOLLITROPIN BETA Full Profile All Ovulation induction Drugs FOLLITROPIN BETA Demographics FOLLITROPIN BETA Timeline